Papa John's Heads Into Q3 Print Under Heavy Short Pressure
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
PZZA arrives at its November 5 earnings report as one of the more heavily shorted names in the restaurant sector, with nearly 20% of its free float sold short and the street firmly on the defensive.
Short interest is running at 19.9% of free float, elevated by any measure, though the trend over the past month has eased: shorts fell roughly 13% from late September peaks, with a further 4% drop in the final session of October. That reduction in positioning has not been accompanied by any meaningful squeeze pressure. Borrow costs are low at 0.76% annually, and availability has loosened sharply from its tightest point of the year. In late September, availability compressed to under 18%, one share available for every six already borrowed. It has since recovered to around 64%, well off those lows, suggesting new shorts can enter without difficulty. Options traders have grown marginally more defensive into the print: the put/call ratio ticked up to 0.31, about one standard deviation above its 20-day average of 0.27, which is cautious but far from extreme given the 52-week high of 1.09.
The analyst community has been cutting targets consistently and without a bullish counterweight in sight. UBS lowered its price target to $21 just two days before the print, down from $28, while maintaining a Neutral rating. Mizuho trimmed to $20 last week. The consensus mean now stands at $28, well above the current price of $18.90, but that gap reflects stale targets rather than genuine optimism: the Street has been in downgrade mode since the second-quarter result delivered an 8.3% North America comparable sales decline. The bear case is straightforward: transaction weakness is broad-based across both carryout and delivery, management cut full-year EBITDA guidance to $180 to $190 million from $200 to $210 million, and the dividend was suspended. Bulls point to the international business, which posted its seventh consecutive quarter of positive comps at +1.5%, and the 42 million Papa Rewards loyalty members who order more frequently and at higher ticket sizes. Neither argument has been enough to stabilise the stock, which has lost roughly half its value year-to-date.
One ownership development worth noting is the arrival of Norbel Inversiones as a new 5% holder, filing a Schedule 13G in October with 1.66 million shares. Earnest Partners and Brandes Investment Partners have also been building positions, each crossing the 8% threshold in recent months. These are passive 13G filings rather than activist 13D disclosures, so there is no campaign on the register, but the accumulation at these price levels signals that some value-oriented buyers see the compression as overdone. Stakes are as-last-disclosed around the 5% threshold, and holders dropping below that level can exit without a further filing.
ORTEX puts the probability of PZZA being deleted from the S&P SmallCap 600 at 57% at the December quarterly review, with the exit price line at $18.23, less than 1.2% below where the stock currently trades. A deletion would trigger an estimated $97 million of forced selling, equivalent to 3.4 days of normal volume. The CRSP US Small deletion is seen as even more likely at 81%. The print on Thursday therefore tests not only whether North America same-store sales can narrow the pace of decline, but whether the stock can hold above the index thresholds that would otherwise bring mechanical selling pressure into year-end.
Stocks in this article
See the live data behind this article on ORTEX.
Open PZZA on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:29
- Data as of
- 3 Nov 2026, 04:28
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.